Your session is about to expire
← Back to Search
OPS Training for Reducing Opioid Overdose Deaths (OPS Trial)
N/A
Waitlist Available
Led By Janie Simmons, EdD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
OPS Trial Summary
This trial will study how best to equip police officers to reduce overdose deaths, which are currently the leading cause of accidental death in the United States.
Who is the study for?
This trial is specifically for active duty police officers. It aims to evaluate their willingness and preparedness to administer naloxone, a medication used to counter the effects of opioid overdose. Officers who are not on active duty or only work at desks are excluded from participating.Check my eligibility
What is being tested?
The study is testing the effectiveness of two web-based training programs: OPS (Opioids and Police Safety Occupational Risk Reduction Training) and its COVID-adapted version. These programs aim to improve safety practices among police when dealing with opioid-related incidents.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there are no direct side effects like those associated with drugs or medical procedures. However, participants may experience stress or emotional discomfort related to the subject matter.
OPS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time frame: the past 30 days at the time the survey is being administered; [data collected: baseline, post intervention: 90 days, 180 days, 270 days, 360 days]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: the past 30 days at the time the survey is being administered; [data collected: baseline, post intervention: 90 days, 180 days, 270 days, 360 days]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Confiscation Behavioral Outcomes in Policing Procedure
Naloxone
Change in Referral Behavioral Outcomes in Policing Procedure
Secondary outcome measures
Needlestick Injuries
Degree of participant awareness of post-exposure prophylaxis (PEP) and its uses
Fentanyl
+1 moreOther outcome measures
Degree of participant familiarity with best-practices related to policing PWUO and PWID who may be carrying heroin contaminated with fentanyl-class substances
Degree of participant familiarity with fentanyl-class substances
Experiences with other programs
+7 moreOPS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Opioids and Police Safety Occupational Risk Reduction TrainingExperimental Treatment1 Intervention
Provides occupational risk reduction training for police in 49 slides including 8 filmed videos (police officers, MDs, SSP staff, a person in recovery). The training is delivered online with secure access only for enrolled study participants.
Group II: COVID Occupational Risk Reduction TrainingActive Control1 Intervention
The COVID-19 and Police Safety training (Control only) includes 22 slides, also narrated by a professional voice narrator.
Find a Location
Who is running the clinical trial?
New York UniversityLead Sponsor
226 Previous Clinical Trials
313,922 Total Patients Enrolled
1 Trials studying Opioid Overdose
39 Patients Enrolled for Opioid Overdose
Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,069 Total Patients Enrolled
1 Trials studying Opioid Overdose
247 Patients Enrolled for Opioid Overdose
Janie Simmons, EdDPrincipal InvestigatorNew York University, School of Global Public Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I work at a desk and am not on active military duty.You are currently working as a police officer.
Research Study Groups:
This trial has the following groups:- Group 1: Opioids and Police Safety Occupational Risk Reduction Training
- Group 2: COVID Occupational Risk Reduction Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger